Top 50 Cardiac Health Monitoring Companies in 2025

Here is a list of the top 50 cardiac health monitoring companies for holistic care that are making a positive impact on society.

The Omdena “Impact Tech Leaders Series” comprises game-changing startups, stories, and thought-leadership pieces from leading impact ventures solving real-world problems.

Introduction

Cardiac health is a crucial aspect of our overall well-being, and regular monitoring can help us stay on top of any potential issues. With advances in technology, cardiac companies are now able to offer a range of innovative solutions to monitor our heart health, providing us with valuable insights and peace of mind. As we move further into 2023, it’s worth exploring the leading cardiac health monitoring companies that are at the forefront of this field. In this article, we will highlight the companies that are offering cutting-edge cardiac health monitoring solutions, helping people take a proactive approach to their heart health and ensuring holistic care. Whether you’re looking for wearable devices, mobile apps, or advanced monitoring systems, these companies are paving the way for the future of cardiac health monitoring.

What is cardiac healthcare?

Cardiac healthcare refers to the medical care and management of heart health and related conditions. The heart is a vital organ that pumps blood throughout the body, and any issues related to its function can have significant consequences on our overall health. Cardiac healthcare involves the diagnosis, treatment, and prevention of conditions that affect the heart and blood vessels, such as heart disease, hypertension, arrhythmias, and heart failure. Healthcare providers in the field of cardiology, including cardiologists and cardiovascular surgeons, are specialized in providing cardiac healthcare services to help patients maintain optimal heart health and prevent or manage any related conditions. Cardiac healthcare may involve a range of treatments, including medication, lifestyle modifications, and surgery, depending on the individual’s condition and needs.

How is AI used in cardiology?

Artificial intelligence (AI) is revolutionizing the field of cardiology and has the potential to improve the diagnosis, treatment, and prevention of heart diseases. Here are some ways AI is used in cardiology:

• Risk prediction: AI algorithms can analyze large datasets of patient health records, lab results, and imaging scans to identify patterns and risk factors for heart diseases. This information can help clinicians make more accurate predictions of a patient’s risk of developing cardiovascular diseases.
• Image analysis: AI can analyze medical images such as echocardiograms, CT scans, and MRIs to identify abnormalities that may be missed by the human eye. This can aid in the early detection and diagnosis of heart diseases.
• Treatment planning: AI algorithms can help clinicians develop personalized treatment plans for patients based on their medical history, risk factors, and other factors.
• Remote monitoring: Wearable devices equipped with AI algorithms can continuously monitor a patient’s heart rate, rhythm, and other vital signs. This can help detect any abnormalities or changes in the patient’s condition and alert healthcare providers to intervene if necessary.
• Drug discovery: AI algorithms can analyze large datasets of molecular and genetic data to identify potential drug targets for heart diseases. This can accelerate the drug discovery process and lead to the development of new treatments.

AI has the potential to transform the field of cardiology by improving the accuracy and efficiency of diagnosis, treatment, and prevention of heart diseases.

The benefits of AI in cardiac health monitoring

AI has numerous benefits in cardiac health monitoring. Here are some of the key advantages:

• Early detection of cardiovascular diseases: AI-powered cardiac health monitoring systems can detect cardiovascular diseases at an early stage. By analyzing the patterns in data from various sources, such as electrocardiograms (ECGs), blood pressure readings, and heart rate variability, AI algorithms can identify abnormalities that might indicate the early stages of heart disease.
• Personalized care: AI can personalize treatment plans for patients by analyzing their health data and identifying specific risk factors. By analyzing patient data, AI can provide personalized treatment recommendations that are tailored to each patient’s unique needs, medical history, and risk factors.
• Improved accuracy and efficiency: AI algorithms can analyze vast amounts of patient data quickly and accurately, which can lead to faster and more accurate diagnoses. This can help physicians make more informed decisions about patient care and reduce the likelihood of misdiagnosis.
• Cost-effective: AI can reduce the costs associated with cardiac health monitoring by improving the efficiency of diagnostic procedures and reducing the need for expensive tests and hospital stays.

Top 50 Cardiac Health Monitoring Companies for Holistic Care in 2025

The order does not follow a ranking.

1. ECG-Excellence

ECG-Excellence develops and markets novel technology in ECG waveform diagnostics. Via their patented solutions, they are able to work with standard 12 lead ECG devices and deliver next-level ECG data interpretation based on digital twin reconstructions, supported by 3D camera-guided electrode placement.

• Founder(s): Hans Slijp
• Founding year: 2019
• Headquarters: Nieuwerbrug, Zuid-Holland, The Netherlands
• Funding: Convertible Note

How do you measure impact?

ECG Excellence has developed CineECG software to support 12 lead-based ECG waveform interpretations.

CineECG is an ECG imaging technology that shows the electrical pathway of the heart activation throughout the heart and compares the recorded values with normal healthy values. This way CineECG provides additional views on the heart performance and outperforms all existing solutions on discriminating between OK and not-OK 12 lead ECG. In primary care up to 95% accuracy is achieved. Applying CineECG for Ischemia detection results in +25% or higher classification. CineECG delivers both clinical added value and reduces over-diagnostic costs up till 35% within the same workflow and reimbursement codes.

In addition, ECG Excellence develops solutions to further increase the clinical value of the 12 lead ECG by enabling effective ECG waveform comparisons over time and offering real-time ECG imaging from 12 lead to monitor treatment effectiveness.

2. Aktiia

Aktiia was founded in 2018 to commercialize its proprietary cuffless optical Blood Pressure Monitoring technology (oBPM™) in order to contribute to the prevention of high blood pressure, to save lives, and to help reduce healthcare costs worldwide. Aktiia is headquartered in Neuchatel (Switzerland), with offices opening up in Zurich (Switzerland) and the USA.

• Founder(s): Josep Sola, Mattia Bertschi
• Founding year: 2018
• Headquarters: Neuchâtel, Neuchatel, Switzerland
• Funding: Series A

3. HD Medical

HD Medical is a global leader in the management of cardiovascular disease & dedicated to enabling evidence-based patient diagnosis.

• Founder(s): Arvind Thiagarajan
• Founding year: 2005
• Headquarters: Santa Clara, California, United States
• Funding: Series Unknown

4. HeartFlow, Inc

HeartFlow is a medical technology company transforming the way cardiovascular disease is diagnosed and treated. With our HeartFlow Analysis, a non-invasive personalized cardiac test, physicians are able to make better care decisions for their patients with suspected coronary artery disease–the number one killer of men and women worldwide.

• Founder(s): Charles A. Taylor, Christopher K. Zarins, John Stevens
• Founding year: 2007
• Headquarters: Redwood City, California, United States
• Funding: Series Unknown

5. CathVision

CathVision develops and markets innovative products for cardiac ablation therapy. The ECGenius System is a next-generation EP system enabling AI algorithms and intelligent decision support.

• Founder(s): Mads Emil Matthiesen, Rune Orndrup, Rune Paamand
• Founding year: 2013
• Headquarters: Copenhagen, Hovedstaden, Denmark
• Funding: Series Unknown

6. Moving Analytics Inc.

Moving Analytics is the leading national telehealth provider of remote cardiac rehab and cardiovascular prevention programs. Their programs combine evidence-based guidelines, behavioral science, remote monitoring, and telehealth coaching to engage patients to adopt heart-healthy lifestyles and improve their well-being.​

• Founder(s): Ade Adesanya, Gaurav S. Sukhatme, Harsh Vathsangam, Shuo Qiao
• Founding year: 2013
• Headquarters: Los Angeles, California, United States
• Funding: Series A

7. Magicardio

Something big always begins with something small. The idea of creating Magicardio came up with a simple wish to take care of cardiovascular patients despite being far from their physicians. 

• Founder(s): Amin Yazdandoost Hamedani, Ali Hajiluyi
• Founding year: 2019
• Headquarters: Tehran, Tehran IR
• Funding: Series Unknown

8. HeartVista

HeartVista is a medical technology company that provides one-click diagnostic imaging. It brought in machine learning to make the scanning process faster, easier, and more consistent. 

• Founder(s): Bob Hu, Juan Santos, William Overall
• Founding year: 2012
• Headquarters: Los Altos, California, United States
• Funding: Series A

9. Hemocath

HemoCath Ltd. is a US/Irish/Canadian pre-revenue startup that has developed and is now commercializing outside the United States the HemoCath pulmonary artery (PA) catheter, indicated for the assessment of a patient’s heart hemodynamic condition through direct simultaneous central venous pressure (CVP) and pulmonary artery pressure (PAP) monitoring.

• Founder(s): Des Regan, Eric Caron, Michael Nagy, ​Christopher Glover
• Founding year: 2014
• Headquarters: Lisle, Illinois, United States
• Funding: Pre-Seed

10. AliveCor Inc.

AliveCor has a device and application that will turn any smartphone into a clinical-quality electrocardiogram (ECG) recorder. AliveCor is pioneering the creation of FDA-cleared ‘machine learning’ techniques to enable proactive heart care and is recognized around the world for transforming cardiac care. It specializes in the fields of healthcare, mobile devices, and medicine.

• Founder(s): Bruce Satchwell, David Albert, Kim Barnett
• Founding year: 2010
• Headquarters: Mountain View, California, United States
• Funding: Series F

11. Medisafe ®

Medisafe ® is a digital patient engagement platform empowering patients to stay on top of all their medications. Its approach leverages the billions of data points collected to personalize patient engagement and improve adherence and persistence to medications.

• Founder(s): Omri Shor, Rotem Shor
• Founding year: 2012
• Headquarters: Boston, Massachusetts, United States
• Funding: Series C

12. Dyad Medical

Dyad Medical, Inc. develops software that automatically analyzes the content of cardiac and cardiovascular images. Their core focus is MRI (heart characterization), CT (aortic valve sizing), Echo (real-time heart characterization for patient triage), and intravascular using optical coherence tomography (IVOCT).

• Founder(s): Annette Shalev, Ronny Shalev
• Founding year: 2018
• Headquarters: Boston, Massachusetts, United States
• Funding: Seed

13. Ultromics

Ultromics is the leader in artificial intelligence for echocardiography enabling earlier detection and risk stratification of heart failure for better outcomes, lower costs, and improved patient care. All providers, regardless of their care setting, can now make precise, accurate, and timely diagnoses of heart failure with Ultromics’ AI technology.

• Founder(s): Paul Leeson, Ross Upton
• Founding year: 2017
• Headquarters: Oxford, Oxfordshire, United Kingdom
• Funding: Series B

14. Cleerly

Cleerly is a digital healthcare company creating a world without heart attacks. We design intelligent clinical technologies to help clinicians precisely identify and define heart disease earlier, so they can provide personalized, life-saving treatment plans for all patients throughout their care continuum.

• Founder(s): James K. Min
• Founding year: 2017
• Headquarters: New York, New York, United States
• Funding: Series C

15. HATO Medical Technologies

HATO Medical Technologies develops and produces advanced medical equipment for the healthcare industry through AI and Big Data. Our state-of-the-art approach towards healthcare challenges the current paradigm and helps save lives.

• Founder(s): Steffen Yndal
• Founding year: 2020
• Headquarters: Odense, Syddanmark, Denmark
• Funding: Pre-Seed

16. Kencor Health

Kencor is focused on creating the best patient experiences in order to reduce readmissions and improve the overall health of communities. Increasing patient engagement and ensuring that providers remain connected is important in creating accessible care for all.

• Founder(s): Muthu Krishnan, Ramani Narayan, Richard Chang
• Founding year: 2015
• Headquarters: Sunnyvale, California, United States
• Funding: Series Unknown

How do you measure impact?

Kencor Health is the only “Remote monitoring”  platform that integrates into any EMR /connects to any IOT vitals devices from Cardiovascular- Endocrinology – Nephrology- Internal Medicine. We have 85%  patient engagement connecting patients and the care team with Kencor Health SAMi platform. We are marching towards getting 50k patients in Kencor Health Platform by end of 2023.

17. MyoKardia

MyoKardia is a clinical-stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. 

• Founder(s): Christine Seidman, James Spudich, Jonathan Seidman, Leslie Leinwand
• Founding year: 2012
• Headquarters: Brisbane, California, United States
• Funding: Series B

18. Shift Bioscience

Shift Bioscience is developing biological-age control to end the diseases of aging, promising a future where you can routinely reset to prime-of-life.

• Founder(s): Daniel Ives
• Founding year: 2017
• Headquarters: Cambridge, Cambridgeshire, United Kingdom
• Funding: Series Unknown

19. FibriCheck

FibriCheck is a digital health company focusing on the development and commercialization of low-cost, scalable, and user-friendly medical grade mobile applications for better health. Their app, FibriCheck, is a CE-certified Class IIa diagnostic solution to detect heart rhythm disorders such as atrial fibrillation outside the clinical environment using the smartphone camera. 

• Founder(s): Bieke Van Gorp, Jo Van der Auwera, Kobe Leysen, Lars Grieten
• Founding year: 2014
• Headquarters: Limburg, Liege, Belgium
• Funding: Series Unknown

20. Volta

Volta Medical leverages artificial intelligence to revolutionize interventional cardiac electrophysiology. Its cutting-edge software solutions use machine learning and deep learning algorithms to assist operators during cardiac ablation procedures.

• Founder(s): Clément Bars, Jerome Kalifa, Julien Seitz, Théophile Mohr Durdez
• Founding year: 2016
• Headquarters: Marseille, Provence-Alpes-Cote d’Azur, France
• Funding: Series B

21. Otitopic Inc.

OtiTopic, Inc., founded in 2012, is a late-stage clinical pharmaceutical company with a track record of success in product drug delivery and drug-device development. 

• Founder(s): Kambiz Yadidi
• Founding year: 2012
• Headquarters: Los Angeles, California, United States
• Funding: Series Unknown

22. NowZone®

Nowzone® App helps every individual undertake programs that are specially designed to reduce stress. The app helps the wandering mind to come to a halt. This is achieved with the ‘Attention Management’ technique- an ancient technique combined with the state of the art technology.

• Founder(s): Akash Madnani, Ritu Nahar, Chetan Borkar, Sudhir Baheti
• Founding year: 2020
• Headquarters: Nagpur, Maharashtra
• Funding: Series Unknown

23. my mhealth

my mHealth is a UK-based team of doctors, engineers, product designers, and digital health advocates creating digital therapeutics and services that help people living with COPD, heart disease, asthma, diabetes, and cancer. They work with the NHS, global health services, insurers, pharma, and life science businesses to create innovative digital solutions that put patients in control of their care.

• Founder(s): Simon Bourne, Tom Wilkinson
• Founding year: 2012
• Headquarters: Bournemouth, Bournemouth, United Kingdom
• Funding: Grant

How do you measure impact?

my mhealth, a digital therapeutics company with over 100,000 users, empowers patients to use clinically proven digital tools to manage their long-term conditions, at a fraction of the cost of traditional care. 

At my mhealth, we believe there is only one measure of the impact that matters; improved patient outcomes. Clinical trials and real-world evidence demonstrates our product has a measurable impact on outcomes such as hospitalization, mortality, and health inequalities. Day-to-day, our team monitors the data from our platform and works closely with patients to ensure that they are interacting with app features that are most meaningful to them- whether it’s a rehabilitation course, medication management, or lifestyle/wellness advice. 

We also have a deep responsibility to ensure our large dataset is leveraged for the greater good, and are working with clinical partners to develop some exciting AI algorithms that will soon predict clinical events, well before they occur.

24. Cardiomatics

Cardiomatics offers cutting-edge, cloud AI-based digital analyses of data from Holter ECGs. Their medical-grade system, based on accurate algorithms, ensure high-quality and trusted outcomes. Healthcare providers can now quickly receive an easy-to-read report and benefit from smarter diagnoses and better workflows.

• Founder(s): Mariusz Masior, Rafal Samborski
• Founding year: 2017
• Headquarters: Kraków, Malopolskie, Poland
• Funding: Seed

25. Spire

Spire Health specializes in continuous respiration sensing and high-adherence, patient-friendly ambulatory monitoring. Its mission is to harness the power of algorithms and sensors to improve health outcomes by empowering patients and physicians with useful and actionable data.

• Founder(s): Jonathan Palley, Neema Moraveji
• Founding year: 2013
• Headquarters: San Francisco, California, United States
• Funding: Series Unknown

26. FineHeart

FineHeart is a French medical device company focused on creating innovative technologies in the cardiovascular space. The patented FineHeart invention, the ICOMS FLOWMAKER® (Implantable Cardiac Output Management System) is the first fully intraventricular, wireless flow accelerator that provides physiological support synchronized with the heart’s natural contractions.

• Founder(s): Arnaud Mascarell, Philippe Ritter, Stéphane Garrigue
• Founding year: 2010
• Headquarters: Bordeaux, Aquitaine, France
• Funding: Series C

27. VPG Medical

VPG Medical Inc. is a digital health service company developing innovative monitoring technologies by leveraging non-contact monitoring based on video cameras. The HealthKam™ technology enables cardiac monitoring during one’s every day activities by acquiring measurements leading to improved diagnoses and therapeutic strategies, and improved health outcomes.

• Founder(s): Jean-Philippe Couderc
• Founding year: 2017
• Headquarters: Rochester, New York, United States
• Funding: Seed

28. CardioLogs

Cardiologs is a medical technology company on a mission to democratize expert cardiac care through medical-grade artificial intelligence.

• Founder(s): Jia Li, Yann Fleureau
• Founding year: 2014
• Headquarters: Paris, Ile-de-France, France
• Funding: Series A

29. OneProject

An innovative med-tech company is developing the next generation of connected intra-vascular medical devices. These devices are designed to improve patient care and provide more accurate data on their health. The devices will be able to monitor and measure vital signs, such as blood pressure and heart rate, as well as other medical data. 

• Founder(s): Christoph Hennersperger, Fionn Lahart
• Founding year: 2017
• Headquarters: Harold’s Cross, Dublin, Ireland
• Funding: Series A

30. Heartbeat

Heartbeat Health is a healthcare technology company that delivers virtual-first cardiovascular disease prevention and management. Through its data-powered platform and clinical services, the company helps patients and at-risk organizations benefit from higher-value care by reducing cardiovascular risk and the likelihood of future adverse events.

• Founder(s): Jeffrey Wessler, Mark Hanson, Nayan Jain
• Founding year: 2017
• Headquarters: New York, New York, United States
• Funding: Series B

31. XOresearch

XOresearch is a company focused on providing deep learning technology to Healthcare. They are highly competent in Deep Learning and other approaches to artificial intelligence and further develop our skills and knowledge

• Founder(s): Maksym Diachenko
• Founding year: 2015
• Headquarters: Riga, Riga, Latvia
• Funding: Series Unknown

32. IDOVEN

Idoven is a health technology company advancing early detection and precision medicine for cardiovascular diseases. The Idoven AI-powered platform delivers substantial improvements to the speed, consistency, and accuracy of electrocardiogram (ECG) interpretation.

• Founder(s): Inigo Juantegui, José María Lillo Castellano, Manuel Marina Breysse
• Founding year: 2018
• Headquarters: Madrid, Madrid, Spain
• Funding: Series A

33. Murj

Murj is a digital health company dedicated to helping clinicians streamline care for patients with implantable cardiac devices. Murj aims to liberate device clinics from paper reports and inadequate management tools, freeing clinicians to get back to the heart of the matter – their patients.

• Founder(s): Chris Irving, Todd Butka
• Founding year: 2014
• Headquarters: Santa Cruz, California, United States
• Funding: Series B

34. HeartLab

HeartLab is a company that is revolutionizing the field of cardiology through the use of artificial intelligence. By leveraging advanced machine learning algorithms, HeartLab is able to provide physicians with the most accurate and up-to-date information about their patients’ cardiovascular health.

• Founder(s): Patrick Gladding, Will Hewitt, Zaid Ismail
• Founding year: 2018
• Headquater(s): Auckland, Auckland, New Zealand
• Funding: Seed

35. Tricog Health

Tricog is on a mission to empower healthcare providers with virtual cardiac diagnostic tools and services that help them in the accurate, timely, and consistent diagnosis of heart conditions. Tricog products – InstaECG and InstaEcho are diagnostic solutions for ECG and Echocardiogram built by combining artificial intelligence and medical expertise to process digital data and deliver an accurate and timely diagnosis of cardiac conditions to save lives.

• Founder(s): Abhinav Gujjar, Charit Bhograj, Udayan Dasgupta, Zainul Charbiwala
• Founding year: 2014
• Headquater(s): Singapore, Central Region, Singapore
• Funding: Series C

36. Vixiar

Vixiar Medical develops non-invasive, cost-effective devices, and systems for monitoring cardiopulmonary diseases, particularly those with a significant clinical and economic burden. The Company’s first product, Indicor, is a handheld point-of-care device and digital platform for monitoring worsening heart failure.

• Founder(s): Harry Silber
• Founding year: 2013
• Headquater(s): Baltimore, Maryland, United States
• Funding: Series A

37. Vector Remote Care

Vector is a complete cardiac digital health solution that makes it simple for care teams to accurately capture, manage, analyze, and act on the growing volume of remote cardiac data. We help monitor and manage the entire cardiac remote data lifecycle – from patient setup to data transmission to analysis – so you can stay focused on what matters most: delivering the best care.

• Founder(s): Kevin Hoffman
• Founding year: 2017
• Headquater(s): Bend, Oregon, United States
• Funding: Series A

38. Sky Labs

Sky Labs spun out of a collaboration project between the Norwegian University of Science and Technology (NTNU) and Wireless Trondheim focused on wireless security and access solutions.

• Founder(s): Matt Makovsky (CEO)
• Founding year: 2019
• Headquater(s): Trondheim, Norway
• Funding: Series Unknown 

39. Eko Health

Eko Health is a digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its suite of AI-powered digital tools.

• Founder(s): Connor Landgraf, Jason Bellet, Tyler Crouch
• Founding year: 2013
• Headquater(s): Oakland, California, United States
• Funding: Grant

40. Cardiolyse

Cardiolyse is a cloud ECG & HRV analytics platform, that enables real-time remote heart health monitoring, providing plain personalized reports, detection, and up to two months of data-based prognosis on dangerous heart events.

• Founder(s): Anna Starynska, Illya Chaikovsky, Irina Zharuk, Nick Papirniy
• Founding year: 2015
• Headquater(s): Helsinki, Southern Finland, Finland
• Funding: Non-equity Assistance

41. Cardiomo Care

AI-based Remote Patient Monitoring solution to deliver real-time, actionable insights to enable early detection of heart diseases.

• Founder(s): Ksenia Belkina
• Founding year: 2016
• Headquater(s): New York, New York, United States
• Funding: Seed

42. Bodyport™

Bodyport™ is a digital therapeutics (DTx) company on a mission: Empower every person to live free from complex chronic conditions — by delivering actionable insights gleaned from unique health signals and simple, at-home experiences. 

• Founder(s): Corey Centen, Sarah Smith
• Founding year: 2014
• Headquater(s): San Francisco, California, United States
• Funding: Series A

43. Implicity

Implicity® is a digital MedTech company – founded by cardiac electrophysiologist Arnaud Rosier MD – that provides a universal cardiac remote monitoring and research platform to hospitals and clinics – helping them provide the best remote care to cardiac patients.

• Founder(s): Arnaud Rosier, David Perlmutter
• Founding year: 2016
• Headquater(s): Paris, Ile-de-France, France
• Funding: Series A

44. HeartHero

HeartHero is a dynamic startup company committed to positively impacting the outcome of Cardiac Arrest and saving more lives through Elliot – a novel, connected Automated External Defibrillator (AED). Cardiac Arrest no longer has to mean Cardiac Death.

• Founder(s): Gary Montagues
• Founding year: 2016
• Headquater(s): Denver, Colorado, United States
• Funding: Series A

45. Verve Therapeutics

Verve Therapeutics is a clinical-stage biotechnology company created with a singular focus: to protect the world from heart disease. Founded by world-leading experts in cardiovascular medicine, human genetics, and gene editing, the company aims to develop transformative, once-and-done therapies for coronary heart disease.

• Founder(s): Anthony Philippakis, Barry Ticho, Burt Adelman, Issi Rozen, J. Keith Joung, Kiran Musunuru, Sekar Kathiresan
• Founding year: 2018
• Headquater(s): Cambridge, Massachusetts, United States
• Funding: Series B

46. SENTINEL HEALTHCARE SOUTH WEST CIC

Sentinel Healthcare South West Community interest Company (CiC) is owned by shareholders of General Practitioners and Practice Managers in Plymouth. As a CiC it has one mission which is: ‘To provide a proactive and innovative leadership role in the planning and delivery of first-class health and social care for the community.’

• Founder(s): LIZ BRIMACOMBE
• Founding year: 2008
• Headquater(s): Plymouth, Plymouth, United Kingdom
• Funding: Series Unknown

47. Bold Diagnostics

Bold Diagnostics is a medical device startup working on developing a diagnostic platform for blood pressure monitoring. This platform utilizes a novel parameter that has not been used before, making it a unique and innovative solution. 

• Founder(s): Kyle Miller, Lauryn Goode, Sean Connell
• Founding year: 2015
• Headquater(s): Chicago, Illinois, United States
• Funding: Convertible Note

48. Heart Health Intelligence (Casana)

Casana is unlocking a new category in healthcare technologies that enable effortless, integrated, and consistent in-home heart health monitoring. Casana’s first product, The Heart Seat™, is an IoT heart health toilet seat that captures clinically relevant measurements, including heart rate, blood pressure, blood oxygenation, and cardiac output.

• Founder(s): Nicholas Conn
• Founding year: 2018
• Headquater(s): Rochester, New York, United States
• Funding: Series B

49. VivaLnk

VivaLnk provides connected healthcare solutions for in-patient and remote patient monitoring. The company’s portfolio includes wearable medical-grade devices and data analytics applications that continuously monitor the health and well-being of individuals.

• Founder(s): Jiang Li
• Founding year: 2014
• Headquater(s): Santa Clara, California, United States
• Funding: Seed

50. Happitech

Happitech is a CE Certified heart rhythm software development kit (SDK) for android and iOS for Remote Patient Management Apps.

• Founder(s): Yosef Safi Harb
• Founding year: 2015
• Headquater(s): Amsterdam, North Holland, Netherlands
• Funding: –

How do you measure impact?

Happitech uses only a smartphone to screen high-risk Atrial Fibrillation patients in 90 seconds.

The challenge of traditional screening is that many patients are asymptomatic or struggle to reach their physician to confirm an episode before it ends. Additionally, it requires expensive, complex equipment and can take months to confirm a diagnosis. Early detection reduces strokes and hospitalizations by initiating treatment earlier. Because our solution works from a smartphone and not a watch like others, we are more accessible to the most likely group to suffer from Afib, the elderly. 63% of retired adults in the US have a smartphone, while only 10% have a smartwatch. Another benefit of using smartphones is that our service can be used anywhere. This improves access to essential services for people who could not afford to undergo screening or live too far away from the doctor. This year, our CE-certified technology will be used in the best Dutch hospitals to reach over 100,000 patients as we expand in Europe and enter the US: achieving our mission to help at-risk people who lack access to care.

Conclusion

The companies listed are driving a new era of cardiac care by combining clinical expertise, sensors, data science, and artificial intelligence. Their innovations make early detection more achievable, remote care more scalable, and chronic condition management more patient friendly. Together they are helping reduce hospital admissions, improve clinical decision making, and expand access to meaningful heart health insights for people and care teams around the world. As technology and evidence advance, these solutions will continue to enable more proactive and personalized cardiac care that saves lives and lowers costs.